-
平臺(tái)編號(hào)：bio-086963
-
國(guó)際編號(hào)：ATCC 53718
-
拉丁屬名： Streptomyces hygroscopicus subsp. hygroscopicus
-
規(guī)格：freeze-dried
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
FD 28576 吸水鏈霉菌吸水亞種*
Streptomyces hygroscopicus subsp. hygroscopicus (Jensen) Waksman and Henrici 拉丁名
ATCC? 53718 統(tǒng)一編號(hào)
Strain Designations 別名 FD 28576 [N 787-182]
Application 用途 Produces C-13 beta-acyloxymilbemycins
Produces N787-182 complex
Isolation 分離基物 Soil, Kurashiki City, Okayama Pref., Japan
Biosafety Level 生物安全等級(jí) 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Preceptrol? no
Type Strain 模式菌種 no
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Medium 培養(yǎng)基 ATCC? Medium 172: N-Z amine with soluble starch and glucose
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度: 26.0°C
Name of Depositor 寄存者 Pfizer, Inc.
U.S. Patent Number 5,573,946
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation 分離基物 Soil, Kurashiki City, Okayama Pref., Japan
References 參考文獻(xiàn) Haxell MA, et al. C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties. J. Antibiot. 45: 659-670, 1992. PubMed: 1624368
Haxell MA, et al. Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds. US Patent 5,573,946 dated Nov 12 1996
Haxell MA, et al. Process for producing antiparasitic macrolide antibiotics. US Patent 5,589,366 dated Dec 31 1996
ATCC? 53718 統(tǒng)一編號(hào)
Strain Designations 別名 FD 28576 [N 787-182]
Application 用途 Produces C-13 beta-acyloxymilbemycins
Produces N787-182 complex
Isolation 分離基物 Soil, Kurashiki City, Okayama Pref., Japan
Biosafety Level 生物安全等級(jí) 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Preceptrol? no
Type Strain 模式菌種 no
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Medium 培養(yǎng)基 ATCC? Medium 172: N-Z amine with soluble starch and glucose
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度: 26.0°C
Name of Depositor 寄存者 Pfizer, Inc.
U.S. Patent Number 5,573,946
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation 分離基物 Soil, Kurashiki City, Okayama Pref., Japan
References 參考文獻(xiàn) Haxell MA, et al. C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties. J. Antibiot. 45: 659-670, 1992. PubMed: 1624368
Haxell MA, et al. Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds. US Patent 5,573,946 dated Nov 12 1996
Haxell MA, et al. Process for producing antiparasitic macrolide antibiotics. US Patent 5,589,366 dated Dec 31 1996
